Search results
Results from the WOW.Com Content Network
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports.
The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO). Within the CDSCO, the Drug Controller General of India (DCGI) regulates pharmaceutical and medical devices and is positioning within the Ministry of ...
Gujarat accounts for a minimum of 28% of India's pharma exports, with exports totalling $5.36bn in 2018–19, up from $4.83bn the previous year. The Indian pharma industry has bounced back with an estimated export value of $19.15bn in 2018–19, an increase of 10.85% over the previous year.
Alembic Pharmaceuticals; Aston Sequoia; Cadila Pharmaceuticals; Century Pharmaceuticals; Deepak Nitrite; Dishman Carbogen Amcis; Indian Petrochemicals Corporation Limited; Intas Pharmaceuticals; National Institute of Pharmaceutical Education and Research, Ahmedabad; Pharmaceutical industry in Gujarat; Pharmaceutical industry in India; Zydus ...
The industry's various subdivisions include distinct areas, such as manufacturing biologics, which are all subject to a variety of laws and regulations that govern the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceuticals market produced treatments worth a total of $1,228.45 billion in 2020.
IPA was founded in August 1999 by Dilip G Shah and six Indian drugmakers: Cipla, Dr. Reddy's, Lupin, Piramal, Ranbaxy, and Wockhardt. [1] IPA was founded to promote the cause of generic drugs in India [2] and has since expanded to include 24 domestic pharmaceutical companies. [3] Sudarshan Jain is the current secretary general of the IPA. [4]
HYDERABAD, India (Reuters) -At least 15 people were killed in an explosion on Wednesday at a pharmaceuticals manufacturing plant in southern India's Andhra Pradesh state, a district government ...
Hetero is a player in the active pharmaceutical ingredients market and finished dosages. [1] It has marketing presence in over 127 countries. Hetero has supplied antiretroviral drugs to patients across more than 100 countries globally.